SINT Sintx Technologies, Inc.: Business Value

SINT (sintx.com) - company brandmark

Sintx Technologies (SINT) develops ultra-high-strength ceramics for aviation, defense, and medicine, which minimizes the risks of dependency on a single sector. This price chart captures the business valuation, which currently stands at 11.35. Management is focused on integrating silicon nitride into new products and achieving product certification. Stable demand for such materials is driving an increase in B2B partners among global medtech manufacturers.

SINT (sintx.com) Total Company Value history from 11/23/2025 to 10/27/2026
Original product of sintx.com

Enterprise Value represents the total cost of acquiring an asset, accounting for all liabilities. By analyzing the Enterprise Value indicator, an investor sees the sum of market capitalization and net debt. This metric allows for an assessment of the business's real scale, stripped of the influence of cash balances. For Sintx Technologies (SINT), this is critical when evaluating resilience against expansion by materials science behemoths. A decrease in this indicator may signal an undervaluation of unique engineering competencies in the production of medical ceramics.

Competing companies

Boston Scientific Corp - Company Buyout Price|Edwards Lifesciences Corp (EW) - Total Company Value|ResMed Corporation (RMD) - Business Value|PODD - Real Price to Acquire Entire Company|ZBH (Zimmer Biomet Holdings) - Aggregate Business Value|COO: Total Company Value|Company Buyout Price ALGN|GMED - Total Company Value|Full Business Value TransMedics Group Inc (TMDX)|ATEC: Enterprise Value|Total Enterprise Value artivion.com AORT|ENOV: Enterprise Value|IART - Real Price to Acquire Entire Company|Motiva - Enterprise Value|iLet Bionic Pancreas (BBNX) - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value EMBC|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AxoGen Inc (AXGN)|Enterprise Value SIBN|OFIX - Company Buyout Price|Real Price to Acquire Entire Company Bioventus Inc.|KIDS - Full Business Value|Enterprise Value TMCI|Blade Air Mobility (SRTA) - Total Enterprise Value|Enterprise Value Carlsmed Corp (CARL)|Business Value RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash STXS (stereotaxis.com)|Neuronetics - Total Company Value|Real Price to Acquire Entire Company Sight Sciences Inc. SGHT|OBIO (Orchestra BioMed, Inc.) - Enterprise Value|ANIK - Total Enterprise Value|Enterprise Value InspireMD, Inc.|Jin Medical (ZJYL) - Business Value|VANI: Enterprise Value|Company Buyout Price Xtant Medical Inc|Enterprise Value NMTC (NeuroOne Corp)|Real Price to Acquire Entire Company modular-medical.com (MODD)|Enterprise Value MYO (Myomo, Inc.)|envoymedical.com - Enterprise Value|VVOS - Total Company Value|enVVeno Medical Corporation (NVNO) - Total Company Value|Real Price to Acquire Entire Company Tenon Medical, Inc TNON|Lifeward Ltd. (LFWD) - Value Adjusted for Debt and Cash|Enterprise Value AMIX (Autonomix Medical Inc.)|Total Enterprise Value IVF|BBLG: Total Company Value|Full Takeover Company Value Axonics Inc. AXNX|Real Price to Acquire Entire Company BIOL (Biolase, Inc.)|Enterprise Value Dynatronics Corp DYNT|Enterprise Value FNA (Paragon 28 Corp)|INVO: Company Buyout Price